St. Jude Medical Reports Second Quarter 2014 Results
ST. PAUL, Minn., Jul 16, 2014 (BUSINESS WIRE) -- St. Jude Medical, Inc. today reported sales and net earnings for the second quarter ended June 28, 2014.
Second quarter highlights:
Net sales increased 3 percent and adjusted net earnings per share increased 6 percent
ICD sales increased 2 percent, demonstrating our continued leadership position in quadripolar CRT therapy
The company completed its acquisition of CardioMEMS, Inc., and began its strategic launch of the CardioMEMS™ HF System, the first and only FDA-approved heart failure monitoring device proven to significantly reduce hospital admissions when used by physicians to manage heart failure
Help employers find you! Check out all the jobs and post your resume.
